Response rates to immunotherapy treatment for prostate cancer patients improves markedly when specific molecular features of the tumour are selected for, a new clinical trial shows.
When given nutritionally matched diets, participants lost twice as much weight eating minimally processed foods compared to ultra-processed foods, according to a new study.
UCLH has been selected as the lead site in Great Britain for Neuralink’s GB-PRIME study, a clinical investigation for Neuralink’s brain-computer interface (BCI).
Initial results from an early phase study demonstrate that patients whose disease has come back showed a 100% overall response rate at the clinically recommended dose in patients who had received previous standard therapies.
Patients with atrial fibrillation who have experienced a stroke would benefit greatly from earlier treatment than is currently recommended in current UK guidelines.
Women and people with a cervix across England who haven’t come forward for vital health checks will be offered home-testing kits as part of the government's cervical screening programme.
A research team has shown for the first time at UCLH that clinical trials can be embedded into everyday care using the hospital’s electronic health records system.
UCL researchers last week ran a highly successful course supported by the BRC aiming to develop the next generation of researchers in biomarkers in neurodegeneration.
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Find out more.
